Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

18.10
Delayed Data
As of Jul 31
 +0.26 / +1.46%
Today’s Change
14.13
Today|||52-Week Range
24.00
-19.38%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close17.84
Today’s open17.98
Day’s range17.86 - 18.63
Volume106,990
Average volume (3 months)246,347
Market cap$559.0M
Dividend yield--
Data as of 3:59pm ET, 07/31/2015

Growth & Valuation

Earnings growth (last year)-120.60%
Earnings growth (this year)+35.99%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book2.77

Competitors

 Today’s
change
Today’s
% change
ABUSTekmira Pharmaceutic...+0.58+5.66%
ADXSAdvaxis Inc+0.84+5.31%
OREXOrexigen Therapeutic...+0.05+1.27%
CHMAChiasma Inc+0.40+1.73%
Data as of 3:59pm ET, 07/31/2015

Financials

Next reporting dateAugust 4, 2015
EPS forecast (this quarter)-$0.64
Annual revenue (last year)$0.00
Annual profit (last year)-$57.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Jay P. Shepard
Chief Financial Officer &
Head-Investor Relations
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts